SCHEMBL4416900

SCHEMBL4416900

CC(=O)NCC(C)CCCCC[C@H]1[C@@H](O)[C@H](OC(=O)O)C[C@H]1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4419137 0.92 — —
SCHEMBL4423884 0.83 GABRR1 (0.32) —
Hydrochloric Acid SCHEMBL4412458 0.82 GABRR1 (0.31) —
SCHEMBL4422850 0.75 — —
SCHEMBL4413595 0.75 — —
SCHEMBL4418062 0.73 KDM1A (0.30) —
SCHEMBL7232199 0.72 — —
Hydrochloric Acid SCHEMBL7233626 0.71 SLC6A12 (0.30) —
SCHEMBL4414950 0.68 BTK (0.34) —
SCHEMBL4411243 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040094-B9 SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARM INC (US) 2015-09-09 — — EP claimed
EP-1040094-B1 SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARM INC (US) 2009-03-18 — — EP claimed
Send feedback